Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Brimonidine for Hemostasis in Eyelid Surgery
NCT05480098Phase 4Withdrawn
- Sponsor
- University of Louisville
- Start
- May 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine transdermal lotion in dermatochalasis, ptosis, Ectropion, Entropion, sponsored by University of Louisville. Planned start May 2022; status: withdrawn.
02
Drugs
brimonidine transdermal lotion
03
Conditions
dermatochalasisptosisEctropionEntropion
Beyond the preview
Go deeper on NCT05480098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05480098.